ASXC CHANCE to make X200 Just buy more ASXC. Long time trade. Maybe a years. But I am will be waiting X200 to my order.Longby farrrgo3
Asensus Surgical Price movementStrong Support: ASXC presents a strong buying opportunity. Market Structure: The daily chart exhibits an inverse head and shoulders pattern. Key Support Level: There is robust support at $0.27. If we close below this level, there's a significant risk of a sharp decline toward $0.18. Major Resistance: A critical resistance line exists at $0.37. This level has been tested more than four times, weakening it progressively. A close above this line in the coming weeks could confirm the inverse head and shoulders pattern. Additionally, a large falling wedge is present, indicating a potential uptrend. Stop Loss: Set at $0.27. Profit Targets: First Target: $0.47. At this point, it's advisable to take 20% of the profits. Second Target: $0.65. Here, taking another 70% of the profits is recommended. Final Target: $1.20. This is the stage where I suggest liquidating the remaining 100% of the position. Risk Management: My strategy involves a structured plan for profit-taking at predetermined levels, which aids in managing risks and securing gains. Please be aware that this analysis represents my perspective and is not professional financial advice. I am not a financial advisor. Each individual should research thoroughly and consider all risks before making investment decisions. Markets are inherently unpredictable, so informed and cautious trading is always advisable.Longby MarketSphere3
ASXC Long term channelEven during the recent high volatility, the long term trend remains very bullish.Longby THeLIStRUpdated 0
Massive wedge with breakout to at least 3.8$This stock will be a massive multi-bagger on good news. Longby THeLIStRUpdated 112
Consolidation + leg upCurrently consolidating previous gains. Probably will reach another high after next week. SL: 0.8Longby THeLIStRUpdated 3
Stock ideaAsensus Surgical (ASXC) potential positive swing with limited downside risk but high upside potential. ASXC announced today the installation of a Senhance® Surgical System in the General Surgery Department of Evangelical Hospital Goettingen-Weende of Göttingen, Germany. This is one of the agreements to lease and utilize the System, which was announced by the company’s plans on 8, August 2022. We expect positive market reaction on this news. In our view, realization of the agreement implies ongoing expansion of the company’s surgical platform in Europe. Growing market share combined with growth in revenues from leasing of the platform should lead to better financial results of ASXC going forward. Technical Chart, 4h, points at a strong support level around price range of $0.50 - $0.51 per share; Upside potential for the near-term trade looks at the price range of $0.60-$0.62 per share, implying at least 11% upside in the short-term. www.tradingview.com by IrinaTK3
Potential Basing Pattern in Asensus SurgicalMy other interpretation is slightly less bullish but still has upside to around $20. This also could be a countertrend interruption to the long term bearish price action which would lead to the stock getting delisted. I see a lot of opportunity here and if this basing pattern holds profits will be insane, but it's definitely a lotto play. There's potential for a bounce off of the 50% retracement, but that's not very likely so I'll wait to buy any significant amount of this one. The call chain is particularly attractive should this play out with prices for ATM and NTM calls for the next several months ranging from $5 - $35 per contract. by EricIkerUpdated 5511
ASXC Ready to make a big move 50%+ and 5x still in PlayCalling a bottom on this one has proven to be difficult, Volume is pretty much non existent and ready for a spike. I am Bullish Longby postman18ny8
#CEDA $ASXC Forecast AnalysisThis is the Forecast of $ASXC Company DISCLAIMER: I am not a financial advisor. All content provided on this channel, and my other social media channels/videos/podcasts/posts, is for entertainment purposes only and reflects my personal opinions. Please do your own research and talk with a financial advisor before making any investing decisions. Longby CEDATrader4
It's been a long time, I should have left you The trend appears to be falling wedge. Typically, a bullish pattern from what I understand. I am an amateur by all means and not financial advice. Longby criscoregelo0
ASXC could be a 5x or moreI believe That ASXC is in a downward consolidation pattern getting ready to break out of a wedge. May drop to as low as RED tab to double test lows after a monstrous run by postman18ny113
ASXC LongWedge breakout near Support Zone entry 1.8 Stop 1.3 Target1 3.6 Target2 6.3 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader. I trade option to test my trading plan with small cost.Longby PlanTradePlanMMUpdated 228
ASXC 1Mtest Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, economic shortcomings in surgery. The Senhance Surgical System features as the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Morrisville, NC. Longby TheCryptoChartWhisperer8
Bull Flag formationchart shows a bull flag consolidation before another bullish period.Longby Scotty-J0
ASXC at a crucial point. ASXC is a company i have done alot of DD on thanks to Deadnsyde who also breaks down the company really well. If you look at other similar companies they are trading at higher prices and this industry isnt that much attractive for now. They arer trying to revolutionize the way doctors conduct surgeries, and are getting very good reviews world wide. Daily chart is showing that the price is at a crucial point and will be interesting to see where the price opens tomorrow morning. Seems like we have broken resistance but is trading right above the line. RSI is heading down, and MACD looks ready to turn red. Will be interesting to see how the week goes for the overall market. Longby Dc13920
$ASXC can rise in the next daysContextual immersion trading strategy idea. Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery in the United States, Europe, and Asia. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $2.70; stop-loss — $2.39. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!Longby KozakHlibUpdated 5
ASXC my super trade hand!!!I’ve done my DD on this both in terms of fundamental and technical analysis and this is my super play it is a 2 year play I would say but the potential profit is amazing Longby TheOracle101228
ASXC LONGThis one I have been watching and in last 6 months. This is a High precision AI enabled Surgical system that we use everyday on millions of surgeries. This got FDA approval and slowly encroaching into the system. This will be Huge play next few years. It crossed golden cross on 12/15/2020 and peaked around 6..8 and consolidating last few months. Double bottomed on 200MA with strong support and now broke the down trend and back above 20MA. Dont look for everyday, Still has plenty of RSI left on monthly bases and will run Huge in next few years. Leave some dead money and sleep peacefully . Go and check the chart of ISRG since 2000-2020 and u will realize what we are dealing here. Longby justimmUpdated 222
$ASXC entry PT 1.55-2 Target PTs 7-20-25 and higherAsensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera; and SurgiBot System, a single-port robotically enhanced laparoscopic surgical platform. Its products also comprise instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is based in Durham, North Carolina.Longby UnknownUnicorn192460154
ASXC - -The shares of Asensus Surgical (NYSEMKT:ASXC) are heating up again among penny stock investors. The ASXC stock price increased as much as 8% in pre-market trading on Wednesday morning after new analyst coverage was announced. -Asensus Surgical is a company pioneering “a new standard of surgery for increased control, less variability and consistently superior outcomes.” The company’s offerings are aimed at integrating machine learning and automated intelligence to improve surgical outcomes. Specifically, Asensus’ focus is on laparoscopic surgical procedures. -Analysts at H.C. Wainwright initiated coverage on ASXC stock today with a “buy” rating. The coverage comes less than two weeks after Asensus released its first-quarter results, reporting revenue of $2.1 million as compared to $600,000 in the three months ended March 31, 2020. Revenue in the first quarter of 2021 included $1.3 million in its Senhance Surgical System sales, $400,000 in instruments and accessories, and $400,000 in services.Longby caldooninvestment1116
ASXC BUY/LONG BIG OPPORTUNITY 2.00 to 8.00++ TICKER CODE: ASXC Company Name: Asensus Surgical, Inc. Industry: Healthcare | Medical Devices | USA Position Proposed: BUY Technical Analysis 1. Large Inverted Head & Shoulders (Forming) 2. Fibonacci Retracement at 0.786 ( Silver Zone) 3. Falling Wedge / Pennant (Nearly Completed) 4. 1st Take Profit will be at Fibonacci Expansion Safe Take Profit and Flagpole Length Entry: NOW READY (2.00-2.40) 1st Partial Take Profit: 8.00 (August-October 2021) 2nd Partial Take Profit: 12.10 (Early-Mid 2022) Full Take Profit: 18.90 (End 2022) Note that timeline buffered, I would expect Full Take Profit by Early 2022Longby traderprosignals4414